We are monitoring the impact of COVID-19 on North America RNA Analysis Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4384
Share on
Share on

North America RNA Analysis Market Research Report - Segmented By End User, Type, Application & Country (US, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, Growth, Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 4384
Pages: 143

North America RNA Analysis Market Size & Growth (2021 to 2026):

According to the report, the North America RNA Analysis Market size is valued at USD 0.98 Billion in 2021 and is expected to grow at a CAGR of 13.7% to reach USD 1.86 billion by 2026 during the forecast period 2021 to 2026.

The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines.

However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent.

This research report on the North America RNA Analysis Market has been segmented and sub-segmented into the following categories

By End User:

  • Academic Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centres

By Type:

  • Microarrays
    • Reagents
    • Instruments
    • Software
  • Polymerase Chain Reaction (PCR)
  • Sequencing Technologies
  • RNAi Gene Silencing

By Application:

  • Clinical Diagnosis
  • Drug Discovery
  • Toxic genomics

By Country:

  • US
  • Canada
  • Rest of North America

On the basis of region, North America accounts for the largest share of the market.

Promising Companies dominating the North America RNA Analysis Market Profiled in the Report are Illumina Inc, Qiagen N.V, Affymetrix Inc, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, Sigma Aldrich, Fluidigm Corporation, Bio-Rad Laboratories Inc, GE Healthcare, and Thermofisher Scientific Inc.

1.Introduction              

                1.1 Market Definition

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions 

2. Research Methodology                       

                2.1 Introduction           

                2.2 Research Phases  

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design     

                2.4 Study Timeline      

3. Overview                   

                3.1 Executive Summary 

                3.2 Key Inferences     

                3.3 Epidemiology          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                

                4.1 Market Drivers      

                4.2 Market Restraints

                4.3 Key Challenges     

                4.4 Current Opportunities in the Market          

5. Market Segmentation                          

                5.1 End-User  

                                5.1.1 Introduction                                                           

                                5.1.2 Academic Research & Government Institutes                                                         

                                5.1.3 Pharmaceutical & Biotechnology Companies                                                           

                                5.1.4 Hospitals & Diagnostic Centers                                                       

                                5.1.5  Y-o-Y Growth Analysis, By End User                                                            

                                5.1.6  Market Attractiveness Analysis, By End User                                                          

                                5.1.7  Market Share Analysis, By End User                                                            

                5.2 Type          

                                5.2.1 Introduction                                                           

                                5.2.2 Microarrays                                                            

                                                5.2.2.1 Reagents                                              

                                                5.2.2.2 Instruments                                        

                                                5.2.2.3 Software                                              

                                5.2.3 Polymerase Chain Reaction (PCR)                                                 

                                                5.2.3.1 Reagents                                              

                                                5.2.3.2 Instruments                                        

                                                5.2.3.3 Software                                              

                                5.2.4 Sequencing Technologies                                                 

                                                5.2.4.1 Sanger Sequencing                                          

5.2.4.1.1 Reagents                          

5.2.4.1.2 Instruments                    

5.2.4.1.3 Software                          

                                                5.2.4.2 Next Generation Sequencing (NGS)                                        

5.2.4.2.1 Reagents                          

5.2.4.2.2 Instruments                    

5.2.4.2.3 Software                          

                               5.2.5 RNAi Gene Silencing                                                           

                                                5.2.5.1 Reagents                                              

                                                5.2.5.2 Instruments                                        

                                                5.2.5.3 Software                                              

                                5.2.6 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.7 Market Attractiveness Analysis, By Type                                                   

                                5.2.8 Market Share Analysis, By Type                                                     

                5.3 Application

                                5.3.1 Introduction                                                           

                                5.3.2 Clinical Diagnosis                                                   

                                5.3.3 Drug Discovery                                                      

                                5.3.4 Toxicogenomics                                                    

                                5.3.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.3.6  Market Attractiveness Analysis, By Application                                                      

                                5.3.7  Market Share Analysis, By Application                                                       

6. Geographical Analysis                          

                6.1 Introduction           

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By End User                                        

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By End User                                        

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By Application                                    

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By End User                                        

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By Application                                    

                6.2 United States        

                6.3 Canada     

7. Strategic Analysis                   

                7.1 PESTLE analysis     

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis          

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                    

                8.1 Affymetrix Inc.      

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Agilent Technologies, Inc.   

                8.3 Bio-Rad Laboratories, Inc.   

                8.4 GE Healthcare       

                8.5 Illumina, Inc.          

                8.6 Qiagen N.V.            

                8.7 F. Hoffmann-La Roche Ltd.

                8.8 Sigma-Aldrich Corporation  

                8.9 Thermo Fisher Scientific, Inc.          

                8.10 Fluidigm Corporation

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of end user, type and application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North America Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America RNA Analysis Market By Technology, From 2021 to 2026 ( USD Billion )
  2. North America Microarray Market By Region, From 2021 to 2026 ( USD Billion )
  3. North America PCR Market By Region, From 2021 to 2026 ( USD Billion )
  4. North America Sequencing Market By Region, From 2021 to 2026 ( USD Billion )
  5. North America RNAi Gene Silencing Market By Region, From 2021 to 2026 ( USD Billion )
  6. North America RNA Analysis Market By Applications, From 2021 to 2026 ( USD Billion )
  7. North America Clinical Diagnostics Market By Region, From 2021 to 2026 ( USD Billion )
  8. North America Drug Discovery Market By Region, From 2021 to 2026 ( USD Billion )
  9. North America Toxicogenomics Market By Region, From 2021 to 2026 ( USD Billion )
  10. North America RNA Analysis Market By End-users, From 2021 to 2026 ( USD Billion )
  11. North America Pharmaceutical and biotechnology Companies Market By Region, From 2021 to 2026 ( USD Billion )
  12. North America Academic Research and Government Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  13. North America Hospitals and Diagnostic Centers Market By Region, From 2021 to 2026 ( USD Billion )
  14. United States RNA Analysis Market By Technology, From 2021 to 2026 ( USD Billion )
  15. United States RNA Analysis Market By Applications, From 2021 to 2026 ( USD Billion )
  16. United States RNA Analysis Market By End-users, From 2021 to 2026 ( USD Billion )
  17. Canada RNA Analysis Market By Technology, From 2021 to 2026 ( USD Billion )
  18. Canada RNA Analysis Market By Applications, From 2021 to 2026 ( USD Billion )
  19. Canada RNA Analysis Market By End-users, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample